290 Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease

Measure Type High Priority Measure? Collection Type(s)
Process no MIPS CQM

Measure Description

Percentage of all patients with a diagnosis of Parkinson’s Disease [PD] who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period.

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.


Instructions

This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s Disease seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.

NOTE: Patient encounters for this measure conducted via telehealth (e.g., encounters coded with GQ, GT, 95, or POS 02 modifiers) are allowable.

Measure Submission Type:

Measure data may be submitted by individual MIPS eligible clinicians, groups, or third party intermediaries. The listed denominator criteria are used to identify the intended patient population. The numerator options included in this specification are used to submit the quality actions as allowed by the measure. The quality-data codes listed do not need to be submitted by MIPS eligible clinicians, groups, or third party intermediaries that utilize this modality for submissions; however, these codes may be submitted for those third party intermediaries that utilize Medicare Part B claims data. For more information regarding Application Programming Interface (API), please refer to the Quality Payment Program (QPP) website.

Denominator

All patients with a diagnosis of Parkinson’s Disease

DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.

Denominator Criteria (Eligible Cases):

All patients regardless of age

AND

Diagnosis for Parkinson’s disease (ICD-10-CM): G20

AND

Patient encounter during the performance period (CPT): 99202, 99203, 99204, 99205, 99211, 99212, 99213, 99214, 99215, 99241*, 99242*, 99243*, 99244*, 99245*, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99421, 99422, 99423, 99441, 99442, 99443, 99483

Numerator

Patients who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period

Definitions:
Assesseduse of a screening tool or discussion with the patient or care partner. Please see “Opportunity for Improvement” section below forsuggestions on possible screening tools.

Psychosis – includes hallucinations, illusions, delusions, paranoia.

Numerator Instructions:
Opportunity for Improvement

The following screening tools may be helpful for use in practice:
For depression:

Geriatric Depression scale Beck Depression

Hamilton Depression scale

Patient Health Questionnaire 2 (PHQ2)

Patient Health Questionnaire 9 (PHQ9)

Montgomery-Asberg Depression Rating Scale (MADRS)

For Anxiety:

Beck Anxiety Inventory

Hospital Anxiety and Depression Scale

Self-rating Anxiety Scale

Anxiety Status Inventory

Strait Trait Anxiety Inventory

Hamilton Anxiety Rating Scale

Parkinson Anxiety Scale
(PAS)

For Psychosis:

Parkinson psychosis rating scale

Rush hallucination inventory

Baylor hallucination questionnaire

Neuropsychiatric inventory (NPI or NPI-Q)

Brief psychiatric rating scale

Positive and negative syndrome scale

Schedule for assessment of positive symptoms

Unified Parkinson disease rating scale Part I

Numerator Options:

Performance Met:

Depression, anxiety, apathy, AND psychosis assessed (G2121)

OR

Performance Not Met:

Depression, anxiety, apathy, AND psychosis not assessed (G2122)


Tags

Quality_2022


Get in touch

Name*
Email*
Message
0 of 350